DE
36
-2
FLR
48
3
WDC
38
-3
MS
80
-3
CMS
58
-2
SRE
66
-3
MRO
46
3
CHRW
67
3
REGN
42
-2
QRVO
4
-2
JBHT
63
-5
PM
58
2
ADM
24
2
FTI
78
-3
SWKS
33
-10
PWR
71
-3
NOC
40
-10
ADI
45
-5
FOX
57
-3
FRT
48
2
DE
36
-2
FLR
48
3
WDC
38
-3
MS
80
-3
CMS
58
-2
SRE
66
-3
MRO
46
3
CHRW
67
3
REGN
42
-2
QRVO
4
-2
JBHT
63
-5
PM
58
2
ADM
24
2
FTI
78
-3
SWKS
33
-10
PWR
71
-3
NOC
40
-10
ADI
45
-5
FOX
57
-3
FRT
48
2
Financhill
Back

Armata Pharmaceuticals 10K Form

Buy
86

ARMP
Armata Pharmaceuticals

Last Price:
2.69
Seasonality Move:
12.82%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ARMP News And Ratings

See the #1 stock for the next 7 days that we like better than ARMP

ARMP Financial Statistics

Sales & Book Value

Annual Sales: $820K
Cash Flow: $-11.54M
Price / Cash Flow: 0
Annual Sales: $-1.28
Price / Book: 0

Profitability

EPS (TTM): -2.35000
Net Income (TTM): $-67.04M
Gross Margin: $410K
Return on Equity: 0%
Return on Assets: 0%

Armata Pharmaceuticals Earnings Forecast

Key Armata Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 19 years for ARMP is 100.24%.
  • The Selling, General & Administrative Expenses for ARMP have been equal to 971.46% of Gross Profit Margin.
  • The Interest Expense is -3.80% of Operating Income.
  • Per Share Earnings over the last 28 years have been positive in 11 years.

Armata Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYAM
Industry: Biotechnology
Sector: Health Care
Current Symbol: ARMP
CUSIP: 04216R
Website: armatapharma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ARMP Technical Analysis vs Fundamental Analysis

Buy
86
Armata Pharmaceuticals (ARMP) is a Buy

Is Armata Pharmaceuticals a Buy or a Sell?